• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-λ4是一种与治疗前丙型肝炎病毒载量相关的细胞自主型III型干扰素。

Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.

作者信息

Lu Yi-Fan, Goldstein David B, Urban Thomas J, Bradrick Shelton S

机构信息

Department of Molecular Genetics and Microbiology, Duke University Medical Center, NC 27710, USA; Center for Human Genome Variation, Duke University Medical Center, NC 27710, USA.

Center for Human Genome Variation, Duke University Medical Center, NC 27710, USA.

出版信息

Virology. 2015 Feb;476:334-340. doi: 10.1016/j.virol.2014.12.020. Epub 2015 Jan 9.

DOI:10.1016/j.virol.2014.12.020
PMID:25577150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4494652/
Abstract

Genetic variants surrounding the interferon-λ3 (IFNL3) gene are strongly associated with clearance of hepatitis C virus (HCV). A variant (rs368234815 TT/ΔG) upstream of IFNL3 was recently implicated to control expression of a novel gene termed IFNL4. We conducted genetic analysis of rs368234815 in a chronic HCV patient cohort and molecular studies of IFNL4 in primary human hepatocytes (PHHs). Analysis of PHHs that are heterozygous at rs368234815 revealed that the IFNL4 transcript isoform is rare, accounting for 2% of transcripts arising from the IFNL4 locus. Nevertheless, IFNL4 over-expression inhibited replication of multiple Flaviviridae and IFNL4 anti-viral potency required the IFNL receptor. In contrast to IFNL3, IFNL4 was inefficiently secreted and appeared to act in a cell-autonomous manner. Genetic analysis revealed associations of rs368234815 with sustained virological response and pre-treatment viral load. The findings suggest that IFNL4 is an atypical IFNL whose activity may be maladaptive to clearance of HCV infection.

摘要

干扰素-λ3(IFNL3)基因周围的遗传变异与丙型肝炎病毒(HCV)的清除密切相关。最近发现IFNL3上游的一个变异(rs368234815 TT/ΔG)可调控一个名为IFNL4的新基因的表达。我们对慢性HCV患者队列中的rs368234815进行了基因分析,并在原代人肝细胞(PHH)中对IFNL4进行了分子研究。对rs368234815杂合的PHH分析显示,IFNL4转录本异构体很少见,占IFNL4基因座产生的转录本的2%。然而,IFNL4的过表达抑制了多种黄病毒科病毒的复制,且IFNL4的抗病毒效力需要IFNL受体。与IFNL3不同,IFNL4分泌效率低下,似乎以细胞自主方式发挥作用。基因分析揭示了rs368234815与持续病毒学应答和治疗前病毒载量的关联。这些发现表明,IFNL4是一种非典型的IFNL,其活性可能不利于HCV感染的清除。

相似文献

1
Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.干扰素-λ4是一种与治疗前丙型肝炎病毒载量相关的细胞自主型III型干扰素。
Virology. 2015 Feb;476:334-340. doi: 10.1016/j.virol.2014.12.020. Epub 2015 Jan 9.
2
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.IFNL4和IFNL3中与丙型肝炎病毒清除相关的功能变异的比较。
J Hepatol. 2015 Nov;63(5):1103-10. doi: 10.1016/j.jhep.2015.06.035. Epub 2015 Jul 15.
3
Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.单核苷酸多态性rs117648444(P70S)导致的混杂因素影响慢性3型丙型肝炎病毒感染患者中干扰素λ基因座变异与干扰素-α-利巴韦林治疗反应的相关性。
J Interferon Cytokine Res. 2017 Aug;37(8):369-382. doi: 10.1089/jir.2017.0002. Epub 2017 Jul 20.
4
Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.干扰素 lambda 4 基因多态性 rs368234815 与血液透析患者丙型肝炎病毒自发清除的关系:一项病例对照研究。
BMC Infect Dis. 2021 Jan 22;21(1):102. doi: 10.1186/s12879-021-05777-6.
5
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.在真实临床环境中,丙型肝炎病毒2/3型慢性丙型肝炎(CHC)患者中干扰素-λ3和干扰素-λ4基因分型的性能和价值
PLoS One. 2015 Dec 23;10(12):e0145622. doi: 10.1371/journal.pone.0145622. eCollection 2015.
6
The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.与丙型肝炎病毒3型(HCV-3)相比,丙型肝炎病毒1型(HCV-1)中IFNL4基因型、肝内干扰素刺激基因表达与干扰素治疗反应之间的关系有所不同。
Aliment Pharmacol Ther. 2015 Aug;42(3):296-306. doi: 10.1111/apt.13263. Epub 2015 Jun 1.
7
Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.肝脏干扰素-λ3(IFNL3)基因表达显示在慢性丙型肝炎中,携带非优势IFNL3 rs4803217或IFNL4 rs368234815次要等位基因的个体中并未减弱。
PLoS One. 2015 Nov 25;10(11):e0143783. doi: 10.1371/journal.pone.0143783. eCollection 2015.
8
IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.IFNL4基因多态性可预测肝移植后丙型肝炎治疗的反应。
J Clin Virol. 2014 Oct;61(2):282-5. doi: 10.1016/j.jcv.2014.07.015. Epub 2014 Jul 30.
9
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.肝 IFNL4 表达与慢性丙型肝炎患者对基于干扰素的治疗无应答相关,通过调节基础干扰素刺激基因表达。
J Med Virol. 2017 Jul;89(7):1241-1247. doi: 10.1002/jmv.24763. Epub 2017 Feb 27.
10
Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.在病例对照研究中鉴定干扰素 lambda 基因座中的因果变异:利用非同义变异 rs117648444 来探究 IFN-λ4 的作用。
Gene. 2018 Jul 20;664:168-180. doi: 10.1016/j.gene.2018.04.076. Epub 2018 Apr 27.

引用本文的文献

1
Structural studies of the IFNλ4 receptor complex using cryoEM enabled by protein engineering.利用蛋白质工程通过冷冻电镜对IFNλ4受体复合物进行结构研究。
Nat Commun. 2025 Jan 18;16(1):818. doi: 10.1038/s41467-025-56119-y.
2
Interferon lambda 4 is a gut antimicrobial protein.干扰素 lambda 4 是一种肠道抗菌蛋白。
Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2409684121. doi: 10.1073/pnas.2409684121. Epub 2024 Oct 22.
3
IFN-λ3 is induced by and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans.

本文引用的文献

1
Interferon-stimulated genes: a complex web of host defenses.干扰素刺激基因:宿主防御的复杂网络。
Annu Rev Immunol. 2014;32:513-45. doi: 10.1146/annurev-immunol-032713-120231. Epub 2014 Feb 6.
2
Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.干扰素 lambda 等位基因预测先天抗病毒免疫反应和丙型肝炎病毒的易感性。
Cell Host Microbe. 2014 Feb 12;15(2):190-202. doi: 10.1016/j.chom.2014.01.007.
3
Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.人肝组织样本中干扰素λ4(IFNL4)转录本的表达
IFN-λ3 可被 诱导,能够在细胞系模型中抑制寄生虫生长,但不能在小鼠模型中抑制,而它在人类中与利什曼病有显著关联。
Infect Immun. 2024 Feb 13;92(2):e0050423. doi: 10.1128/iai.00504-23. Epub 2024 Jan 9.
4
The Role of Ku70 as a Cytosolic DNA Sensor in Innate Immunity and Beyond.Ku70 在固有免疫及其他方面作为细胞质 DNA 传感器的作用
Front Cell Infect Microbiol. 2021 Oct 21;11:761983. doi: 10.3389/fcimb.2021.761983. eCollection 2021.
5
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses.干扰素 lambda 4 可损害丙型肝炎病毒抗原呈递并减弱 T 细胞应答。
Nat Commun. 2021 Aug 12;12(1):4882. doi: 10.1038/s41467-021-25218-x.
6
Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes.单核细胞在人 IFN-λ3 或 IFN-λ4 的存在下分化为巨噬细胞和树突状细胞,表现出不同的表型。
J Leukoc Biol. 2021 Aug;110(2):357-374. doi: 10.1002/JLB.3A0120-001RRR. Epub 2020 Nov 17.
7
Innate Immunity in Hepatitis C Virus Infection.丙型肝炎病毒感染中的固有免疫
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):a036988. doi: 10.1101/cshperspect.a036988.
8
Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals.丙型肝炎病毒感染肝细胞中的干扰素反应:直接作用抗病毒药物时代需要考虑的问题。
Int J Mol Sci. 2020 Apr 8;21(7):2583. doi: 10.3390/ijms21072583.
9
Macrophage Coordination of the Interferon Lambda Immune Response.巨噬细胞对干扰素 lambda 免疫反应的协调作用。
Front Immunol. 2019 Nov 19;10:2674. doi: 10.3389/fimmu.2019.02674. eCollection 2019.
10
The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.干扰素 λ4 之谜:好干扰素为何会变糟。
J Interferon Cytokine Res. 2019 Oct;39(10):636-641. doi: 10.1089/jir.2019.0044. Epub 2019 Jun 26.
PLoS One. 2013 Dec 20;8(12):e84026. doi: 10.1371/journal.pone.0084026. eCollection 2013.
4
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.有利的 IFNL3 基因型可逃避 AU 富含元件和丙型肝炎病毒诱导的 microRNAs 介导的 mRNA 衰变。
Nat Immunol. 2014 Jan;15(1):72-9. doi: 10.1038/ni.2758. Epub 2013 Nov 17.
5
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses.干扰素 lambda 4 通过 IFNλ 受体发出信号,调节针对 HCV 和冠状病毒的抗病毒活性。
EMBO J. 2013 Nov 27;32(23):3055-65. doi: 10.1038/emboj.2013.232. Epub 2013 Oct 29.
6
Global control of hepatitis C: where challenge meets opportunity.全球丙型肝炎控制:挑战与机遇并存。
Nat Med. 2013 Jul;19(7):850-8. doi: 10.1038/nm.3184.
7
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.IL28B 的表达取决于一种新的 TT/-G 多态性,这种多态性提高了 HCV 清除的预测效果。
J Exp Med. 2013 Jun 3;210(6):1109-16. doi: 10.1084/jem.20130012. Epub 2013 May 27.
8
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.IFNL3(IL28B)上游的一种变体创造了一个新的干扰素基因 IFNL4,与丙型肝炎病毒清除能力受损有关。
Nat Genet. 2013 Feb;45(2):164-71. doi: 10.1038/ng.2521. Epub 2013 Jan 6.
9
IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.IL-29 是丙型肝炎病毒感染期间肝细胞产生的主要 III 型干扰素。
Hepatology. 2012 Dec;56(6):2060-70. doi: 10.1002/hep.25897. Epub 2012 Nov 19.
10
Interferon-stimulated genes and their antiviral effector functions.干扰素刺激基因及其抗病毒效应功能。
Curr Opin Virol. 2011 Dec;1(6):519-25. doi: 10.1016/j.coviro.2011.10.008.